riluzole / Generic mfg. 
Welcome,         Profile    Billing    Logout  

24 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
riluzole / Generic mfg.
2017-001481-23: NA NA

Not yet recruiting
3
50
Europe
Riluzole PMCS, Tablet, Riluzole PMCS
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP), Ministère des Solidarités et de la Santé
SCA2 patients, both gender, at least 18 years of age Patients SCA2, homme et femme, âgé d'au moins 18 ans, NA Ataxie, Diseases [C] - Nervous System Diseases [C10]
 
 
2021-002011-61: Riluzole as treatment for psychotic and cognitive symptoms in 22q11.2 deletion syndrome Riluzol als behandeling voor psychotische en cognitieve symptomen in 22q11.2 deletie syndroom.

Ongoing
3
45
Europe
Riluzole, EMEA/H/C/000109, Tablet, Rilutek
Academisch ziekenhuis Maastricht, Academisch ziekenhuis Maastricht
22q11.2 deletion syndrome 22q11.2 deletie syndroom, 22q11.2DS 22q11.2DS, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
ALSummit, NCT04745299: Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

Active, not recruiting
3
115
RoW
Lenzumestrocel, Neuronata-R inj, Autologous Bone Marrow derived Mesenchymal Stem Cell, Riluzole, Rilutek, Placebo Comparator, Normal Saline Inj.
Corestemchemon, Inc.
Amyotrophic Lateral Sclerosis
12/24
05/26
NCT03127267 / 2019-001862-13: Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Recruiting
3
495
Europe, US, RoW
Masitinib (6.0), AB1010, Riluzole, Rilutek, Placebo, Placebo Oral Tablet, Masitinib (4.5)
AB Science
Amyotrophic Lateral Sclerosis
12/23
12/23
ChiCTR2300074440: A multicenter,randomized controlled trial assessing the efficacy of Riluzole in facilitating the repairement of spinal cord

Not yet recruiting
3
90
 
Given methylprednisolone (80mg, bid, 1 week before admission), cobamamide (500ug, qd, 2 weeks after admission) and lansoprazole (100mg within 24 hours after admission, bid, po, then 50mg bid for 13 days after admission) treatment.; Given methylprednisolone (80mg, bid, 1 week before admission), mecobalamin (500ug, qd, 2 weeks after admission), and placebo treatment with the same appearance as liruzole (normal saline) (same frequency and quantity as liruzole).
Jiangsu Province Hospital; Jiangsu Province Hospital, The funding comes from the National Natural Science Foundation of China, with the grant number:82272499.
spinal cord injury
 
 
NCT04950933: The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules

Recruiting
2/3
144
RoW
Huolingshengji Granules, Riluzole tablet
Peking University Third Hospital, The Second Hospital of Hebei Medical University
Amyotrophic Lateral Sclerosis
12/21
12/22
2014-002627-10: Pivotal study to evaluate the efficacy and safety of riluzole versus mexiletine in patients with non dystrophic myotonia mutated in SCN4A orCLCN1 genes. Studio clinico pilota per valutare l'efficacia e la sicurezza di riluzolo rispetto mexiletina in pazienti affetti da miotonia non distrofica mutati nei geniSCN4A o CLCN1.

Ongoing
2
58
Europe
RILUZOLO, Capsule, hard, RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA, MINISTERO DELLA SALUTE - FONDI 5 X 1000
NDM patients with mutations in SCN4A or CLCN1 gene Miotonie non distrofiche con mutazione nei geni SCN4A o CLCN1, Patients with myotonic phenomenon Pazienti con fenomeno miotonico, Diseases [C] - Nervous System Diseases [C10]
 
 
2018-000282-37: Riluzole in spinocerebellar ataxia type 7 Riluzolo in pazienti affetti da Atassia Spinocerebellare di tipo 7

Not yet recruiting
2
34
Europe
Glentek 50 mg compresse rivestite con film, [Glentek 50 mg compresse rivestite con film], Coated tablet, Glentek 50 mg film-coated tablets
DIPARTIMENTO DI NEUROSCIENZE SALUTE MENTALE E ORGANI DI SENSO - NESMOS - SAPIENZA UNIVERSITÀ DI ROMA, AIFA - Italian Medicines Agency
Spinocerebellar ataxia type 7 (SCA7) Atassia spinocerebellare di tipo 7 (SCA7), Spinocerebellar ataxia type 7 (SCA7) Atassia spinocerebellare di tipo 7 (SCA7), Diseases [C] - Nervous System Diseases [C10]
 
 
2021-001989-38: COMPARISON OF THE COMBINED TREATMENT OF THE LIPOSOMATED POLYPHENOLS CÚRCULA AND RESVERATROL® WITH DUTASTERIDE, IN THE IMPROVEMENT OF PATIENTS WITH ELA WHO ARE BEING TREATED WITH RILUZOLE COMPARACION DEL TRATAMIENTO COMBINADO DE LOS POLIFENOLES LIPOSOMADOS CÚRCULA Y RESVERATROL® CON DUTASTERIDA, EN LA MEJORA DE PACIENTES CON ELA QUE ESTÉN SIENDO TRATADOS CON RILUZOL

Ongoing
2
100
Europe
Dutasterida, Capsule, soft, Dutasterida
Facultad de medicina y ciencias de la salud de la Universidad Católica de Valencia, FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD DE LA UNIVERSIDAD CATÓLICA DE VALENCIA
Amyotrophic Lateral Sclerosis Esclerosis lateral amiotrófica, Amyotrophic Lateral Sclerosis Esclerosis lateral amiotrófica- ELA, Diseases [C] - Nervous System Diseases [C10]
 
 
2021-003875-32: Clinical trial to assess the safety and efficacy of IFB-088 plus riluzole 100 mg vs placebo plus riluzole 100 mg in patients with bulbar-onset amyotrophic lateral sclerosis

Not yet recruiting
2
50
Europe
Icerguastat, IFB-088, Tablet
InFlectis BioScience, InFlectis BioScience,
Amyotrophic lateral sclerosis (bulbar-onset), Amyotrophic lateral sclerosis, Diseases [C] - Nervous System Diseases [C10]
 
 
ChiCTR2100044085: A multicenter, randomized, double-blind, positive drug parallel controlled clinical trial to evaluate the efficacy and safety of Huolingshengji Keli granules for the treatment of amyotrophic lateral sclerosis (ALS).

Recruiting
2
144
 
Huoling Shengji Keli granules 1 bag + riluzole tablets simulant 1 tablet each time, Bid, oral ;Huoling Shengji Keli granules simulant 1 bag + riluzole tablets 1 tablet each time, Bid, oral
Peking University Third Hospital; Foshan Kaichuan Pharma Co.Ltd, Foshan Kaichuan Pharma Co.Ltd
Amyotrophic lateral sclerosis
 
 
SOLUTION, NCT05292209: RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring

Recruiting
2
78
US
Riluzole 50 MG
University of Utah, Ohio State University
Atrial Fibrillation Paroxysmal
10/24
10/24
RILUSCI, NCT02859792: Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition

Recruiting
2
90
Europe
Riluzole, Placebo, Blood Samples
Assistance Publique Hopitaux De Marseille
Spinal Cord Injury
11/23
12/23
RILUZOX-01, NCT03722680 / 2017-002320-25: Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.

Active, not recruiting
2
80
Europe
Riluzole, Placebo Oral Tablet
UNICANCER
Oxaliplatin-induced Peripheral Neuropathy
09/24
10/24
NCT06580002: Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial

Not yet recruiting
2
34
NA
University of California, Irvine
Breast Cancer
09/25
09/26
NCT05508074: Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)

Active, not recruiting
2
51
Europe
IFB-088 50mg/day, IFB-088, Icerguastat, Placebo, Riluzole 100mg/day, Riluzole
InFlectis BioScience
Amyotrophic Lateral Sclerosis, ALS
01/25
01/25
NCT04326283: Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Terminated
1/2
23
RoW
Trametinib (0.5 mg), Meqsel, SNR1611, Trametinib (1 mg), Riluzole (100 mg), Yooritek
Genuv Inc.
Amyotrophic Lateral Sclerosis
04/23
04/23
NCT01303341: Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Active, not recruiting
1
35
US
Laboratory Biomarker Analysis, Pharmacological Study, Riluzole, Rilutek, Sorafenib Tosylate, BAY 43-9006 Tosylate, BAY 54 9085, BAY 54-9085, BAY 549085, BAY-54-9085, BAY549085, Nexavar, sorafenib
National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm, Recurrent Melanoma, Refractory Malignant Solid Neoplasm, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
05/12
09/25
RESTORE, NCT06270108: The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

Recruiting
1
288
Europe
Riluzole
King's College London, South London and Maudsley NHS Foundation Trust
Treatment-resistant Schizophrenia, Treatment-responsive Schizophrenia, Healthy Controls
12/24
12/24
NCT04761614: Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Active, not recruiting
1
13
US
Bevacizumab, Anti-VEGF, Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF rhuMAb, Avastin, Bevacizumab awwb, Bevacizumab Biosimilar BEVZ92, Bevacizumab Biosimilar BI 695502, Bevacizumab Biosimilar CBT 124, Bevacizumab Biosimilar CT-P16, Bevacizumab Biosimilar FKB238, Bevacizumab Biosimilar GB-222, Bevacizumab Biosimilar HD204, Bevacizumab Biosimilar HLX04, Bevacizumab Biosimilar IBI305, Bevacizumab Biosimilar LY01008, Bevacizumab Biosimilar MIL60, Bevacizumab Biosimilar Mvasi, Bevacizumab Biosimilar QL 1101, Bevacizumab Biosimilar RPH-001, Bevacizumab Biosimilar SCT501, Bevacizumab Biosimilar Zirabev, Bevacizumab-awwb, Bevacizumab-bvzr, BP102, BP102 Biosimilar, HD204, Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer, Mvasi, Recombinant Humanized Anti-VEGF Monoclonal Antibody, rhuMab-VEGF, SCT501, Zirabev, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Riluzole, Rilutek
Ning Jin
Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
05/23
12/24
ChiCTR-IOR-14005674: Open randomized controlled trial of the Jianpi Yifei Decoction in the treatment of bulbar paralysis of amyotrophic lateral sclerosis

Not yet recruiting
N/A
60
 
Jianpi Yifei Decoction ;Riluzole
Guangdong Province Traditional Chinese Medical Hospital; Guangdong Province Traditional Chinese Medical Hospital, dedicated study foundation of Guangdong Province Traditional Chinese Medical Hospital
amyotrophic lateral sclerosis
 
 
NCT03537807: Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

No Longer Available
N/A
NA
Riluzole, Riluzole Zydis® sublingual
Biohaven Pharmaceuticals, Inc.
Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease, Lou Gehrig's Disease, Lou-Gehrigs Disease, Motor Neuron Disease, Amyotrophic Lateral Sclerosis
 
 
ChiCTR2000035988: Exploratory study of wearable low-intensity ultrasound in the disease progression of Amyotrophic lateral sclerosis

Not yet recruiting
N/A
50
 
wearable low-intenstiy ultrasound + riluzole ;invalid ultrasound + riluzole
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, Not stated
Amyotrophic lateral sclerosis
 
 
ChiCTR2000028960: Exploratory study of low-intensity ultrasound in the disease progression of amyotrophic lateral sclerosis

Not yet recruiting
N/A
40
 
wearable low-intensity ultrasound and Riluzole ;ineffective ultrasound and Riluzole
University Affiliated Sixth People's Hospital; University Affiliated Sixth People's Hospital, University Affiliated Sixth People's Hospital
Amyotrophic lateral sclerosis
 
 

Download Options